News
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback